Status:
RECRUITING
Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.
Lead Sponsor:
Fairtility
Conditions:
Fertility Disorders
Eligibility:
FEMALE
18+ years
Brief Summary
This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine lear...
Detailed Description
The CHLOE-OQ Data Collection Protocol is designed to support the reliable and robust development of the CHLOE technology-based application, ensuring their accuracy and effectiveness in assessing oocyt...
Eligibility Criteria
Inclusion
- Women at least 18 years of age.
- Embryos or eggs cultured in a time-lapse incubator connected to CHLOE Embryo Viewer.
Exclusion
- Women with autologous eggs
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06928337
Start Date
May 1 2025
End Date
May 1 2026
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The World Egg and Sperm Bank
Scottsdale, Arizona, United States, 85260